Corvus Pharmaceuticals Inc. – Filings and Transcripts

NASDAQ: CRVS
Share price (11/6/26): $10.54
Market cap (11/6/26): $889 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 09/30/26 Q3

ended 06/30/26 Q2

ended 03/31/26 Q1

ended 12/31/25 FY 2025

ended 09/30/25 Q3

Prospectuses and Registrations Filter

Registration of securities for employees

Prospectus supplement for primary offering

Automatic shelf registration

Prospectus supplement for primary offering

Addition of securities to prior shelf registration

Ownership Filter

State Street Corporation

Moore David Scott

News Filter

Provides Business Update and Reports Third Quarter 2026 Financial Results

Provides Business Update and Reports Second Quarter 2026 Financial Results

Change in Directors, Officers or Compensation

Shareholder Vote Results

Presents Soquelitinib Phase 1 Atopic Dermatitis Data at the Society for Investigative Dermatology (SID) Annual Meeting

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Other Filter

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Notice of effectiveness

Correspondence with the SEC